More on MBX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (9.2 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

MBX Biosciences (NQ:MBX)
Delayed: 49.61 -1.1 (2.17%)
Prev. Close $50.71  
Open$50.69 
52 Wk High$ 
52 Wk Low$ 
Day High$50.88 
Day Low$49.23 
P/E N/A  
EPS$ 
Volume818,922 

Friends, Peers and Foes (?): MBXBF, ARQT, GNLX, NAMS, KLRA (more...)

Oct 13, 2026 08:01 AM MBX Biosciences to Participate in Upcoming November Investor Conferences
Oct 12, 2026 05:15 AM MBX Biosciences Inc (MBX) PT Raised to $84 at Stifel
Oct 8, 2026 07:01 AM Microbix Making Keynote Presentation at Masters Summit 2026
Oct 2, 2026 06:46 AM MBX Biosciences Inc (MBX) PT Raised to $150 at Guggenheim
Sep 28, 2026 09:41 AM UBS Reiterates Buy Rating on MBX Biosciences Inc (MBX), Says Stock Remains Undervalued
Sep 23, 2026 07:01 AM Microbix Presenting at Muskoka Capital Event
Sep 9, 2026 07:01 AM Microbix Qualifies as Supplier for Five Major Dx Test-Makers Product Lines for Support of Leading IVD Manufacturers
Aug 27, 2026 08:35 AM Form 8-K MBX Biosciences, Inc. For: Aug 27
Aug 27, 2026 08:01 AM MBX Biosciences doses first patient in Phase 3 hypoparathyroidism trial
Aug 27, 2026 08:00 AM MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism
View All Articles

Entities mentioned with MBX

View All Entities